|6.02||-0.02 / -0.33%|
Data as of 4:00pm ET
|6.02||0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +82.72% increase from the last price of 6.02.
The current consensus among 8 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.